04:53:41 EDT Thu 18 Jul 2024
Enter Symbol
or Name
USA
CA



T:HLS - HLS THERAPEUTICS INC. J - http://www.hlstherapeutics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
HLS - T  0.83.45·3.660.53.452.48123.47  3.47  3.457.12  3.25Jul 17Jul 0215 min RT 2¢
TSX - T0.83.45·3.660.53.452.1773.47  3.47  3.457.12  3.25Jul 1715 min
Chi-X - X 3.450.3133.47  3.47  3.45Jul 1715 min
CXD - D 3.450.0051    Jul 1115 min
TriAct - M 3.450.0051    Sep 11/2015 min

Recent Trades - Last 10 of 12
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-07-02 11:20C:HLS3.35News ReleaseHLS Therapeutics sells Xenpozyme royalty interest
2024-06-07 19:10C:HLS3.65News ReleaseHLS Therapeutics shareholders elect eight directors
2024-05-28 10:45C:HLS3.70News ReleaseHLS talks PSPs, clozapine treatment study results
2024-05-09 11:00C:HLS4.15News ReleaseHLS Therapeutics loses $6.1-million (U.S.) in Q1 2024
2024-05-09 07:20C:HLS4.78SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-05-09 07:20C:HLS4.78SEDAR Interim MD & ASEDAR Interim MD & A
2024-04-25 12:42C:HLS4.75News ReleaseHLS to release fiscal Q1 2024 results May 9
2024-04-08 10:27C:HLS5.04News ReleaseHLS Therapeutics touts Vascepa for MACE reduction
2024-03-14 16:06C:HLSSEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-14 12:11C:HLS4.34SEDAR MD & ASEDAR MD & A
2024-03-14 12:11C:HLS4.34SEDAR Annual Information FormSEDAR Annual Information Form
2024-03-14 12:11C:HLS4.34SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-14 10:25C:HLS3.99News ReleaseHLS Therapeutics loses $27.53M (U.S.) in fiscal 2023
2024-02-29 10:27C:HLS4.00News ReleaseHLS Therapeutics to release 2023 results March 14
2024-02-06 10:00C:HLS4.25News ReleaseHLS to list Vascepa under with B.C. drug plan
2023-12-18 09:53C:HLS3.67News ReleaseHLS Therapeutics CFO Hendrickson to step down
2023-11-14 17:52C:HLS3.73News ReleaseHLS study finds Vascepa lowers cardio risk in patients
2023-11-10 08:23C:HLS4.07In the NewsGlobe says Keywood cuts HLS Therapeutics to "hold"
2023-11-09 10:08C:HLS4.86News ReleaseHLS Therapeutics loses $6.9-million (U.S.) in Q3 2023
2023-11-09 09:38C:HLS4.86SEDAR Interim MD & ASEDAR Interim MD & A